Free Trial
NASDAQ:BBNX

Beta Bionics (BBNX) Stock Price, News & Analysis

Beta Bionics logo
$15.00 -0.36 (-2.34%)
As of 09:08 AM Eastern

About Beta Bionics Stock (NASDAQ:BBNX)

Key Stats

Today's Range
$15.00
$15.00
50-Day Range
$9.71
$15.84
52-Week Range
$8.89
$24.50
Volume
2,453 shs
Average Volume
473,403 shs
Market Capitalization
$650.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.83
Consensus Rating
Moderate Buy

Company Overview

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Receive BBNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter.

BBNX Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Beta Bionics, Inc. (BBNX)
Beta Bionics: Slowing Down Or Being Conservative?
Beta Bionics to Host Investor Event on June 22, 2025
See More Headlines

BBNX Stock Analysis - Frequently Asked Questions

Beta Bionics' stock was trading at $23.81 on January 1st, 2025. Since then, BBNX shares have decreased by 35.5% and is now trading at $15.36.
View the best growth stocks for 2025 here
.

Beta Bionics, Inc. (NASDAQ:BBNX) issued its earnings results on Tuesday, May, 6th. The company reported ($0.52) EPS for the quarter, missing analysts' consensus estimates of ($0.51) by $0.01.
Read the conference call transcript
.

Beta Bionics (BBNX) raised $204 million in an initial public offering (IPO) on Thursday, January 30th 2025. The company issued 12,000,000 shares at $17.00 per share.

Beta Bionics' lock-up period expires on Tuesday, July 29th. Beta Bionics had issued 12,000,000 shares in its initial public offering on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

Top institutional shareholders of Beta Bionics include Eventide Asset Management LLC (11.37%), Wellington Management Group LLP (9.00%), Sands Capital Ventures LLC (7.16%) and Omega Fund Management LLC (4.59%). Insiders that own company stock include Hadley Harbor Aggre Wellington and Mike Mensinger.
View institutional ownership trends
.

Shares of BBNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/06/2025
Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BBNX
Previous Symbol
NASDAQ:BBNX
Web
N/A
Fax
N/A
Employees
294
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$24.83
High Stock Price Target
$30.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+61.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$69.83 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$665.95 million
Optionable
N/A
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:BBNX) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners